Description:

NCIC MA.32 End of Treatment Form A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=80D68B0D-F9C5-D6E6-E040-BB89AD43104A

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=80D68B0D-F9C5-D6E6-E040-BB89AD43104A

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 1/8/15
  3. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT01101438 Off Treatment - NCIC MA.32 End of Treatment Form - 3018635v1.0

The purpose of the "End of Treatment Report" is to collect information at the end of protocol treatment. The "End of Treatment Report" should be completed at the time protocol treatment is permanently discontinued.

Off Protocol Therapy
Reason Treatment Ended
Attribution
End Of Treatment Glucose
Was sample obtained
mg/dL
mg/dL
mg/dL

Similar models